Andrew S. Levey, MD; Katrin Uhlig, MD, MS
Note: Dr. Levey was the Work Group Chair and Dr. Uhlig was the Assistant Director of the Evidence Review Team for the National Kidney Foundation K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (1).
Acknowledgments: The authors thank Sara L. Pressel, MS, Barry R. Davis, MD, PhD, Jeffrey A. Cutler, MD, MPH, and Mahboob Rahman, MD, MS for providing additional data from ALLHAT; Panagiotis Vlagpoulos, MD, Mei Chung, MPH, and Joseph Lau, MD, for assistance in data synthesis; and Rebecca Persson for editorial assistance.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Katrin Uhlig, MD, MS, Division of Nephrology, Tufts-New England Medical Center, 750 Washington Street, Boston, MA 02111; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. Levey and Uhlig: Division of Nephrology, Tufts-New England Medical Center, 750 Washington Street, Boston, MA 02111.
Levey AS, Uhlig K. Which Antihypertensive Agents in Chronic Kidney Disease?. Ann Intern Med. 2006;144:213–215. doi: 10.7326/0003-4819-144-3-200602070-00011
Download citation file:
Published: Ann Intern Med. 2006;144(3):213-215.
Cardiology, Chronic Kidney Disease, Coronary Risk Factors, Hypertension, Nephrology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use